+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Plasma Fractionation Market by Product, Application, End-User - Global Forecast 2025-2030- Product Image
Plasma Fractionation Market by Product, Application, End-User - Global Forecast 2025-2030- Product Image
Sale

Plasma Fractionation Market by Product, Application, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 188 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5336507
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Plasma Fractionation Market grew from USD 35.52 billion in 2023 to USD 38.95 billion in 2024. It is expected to continue growing at a CAGR of 10.45%, reaching USD 71.27 billion by 2030.

Plasma fractionation involves the process of separating various components of blood plasma to produce different plasma-based products, such as albumin, immunoglobulins, and clotting factors, which are used in therapeutic treatments. The necessity of plasma fractionation arises from its critical role in treating immune disorders, hemophilia, and other chronic diseases. Key applications extend to healthcare providers utilizing these products for therapies related to immunodeficiencies, coagulation deficiencies, and critical care. The end-use scope primarily comprises hospitals, clinics, and research institutions. Market growth is influenced significantly by a rising prevalence of immune and bleeding disorders, increasing adoption of plasma-derived therapies, and advancements in purification and fractionation processes improving product efficacy. There's a burgeoning demand, particularly in emerging economies, driven by improving healthcare infrastructure and rising awareness about plasma therapy benefits. Potential opportunities lie in expanding plasma collection pools to meet increasing demands, geographic expansion to underserved regions, and innovations in recombinant technology as an alternative to traditional plasma fractionation. However, the market faces limitations like high costs associated with plasma products and regulatory complexities that can stymie swift product approvals. Challenges include the ethical and logistical difficulties in plasma collection and concerns over viral transmissions. Innovation can be fostered in developing more efficient fractionation techniques and improving product safety through pathogen reduction technologies. Moreover, research can focus on synthetic biology to create biosimilar plasma products. Overall, the plasma fractionation market presents a blend of challenges and prospects, wherein businesses must adapt to evolving therapeutic needs and technological advancements. Strategic partnerships with healthcare providers and investment in R&D are crucial recommendations for leveraging market opportunities. The market is dynamic with a potential shift towards increased emphasis on sustainability and self-sufficiency in plasma supply chains, suggesting a ripe ground for innovation in collection methodologies and distribution logistics.

Understanding Market Dynamics in the Plasma Fractionation Market

The Plasma Fractionation Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Improving access to plasma-based therapies and high use of immunoglobulins in various therapeutic areas
    • Government initiatives to increase plasma collection
    • Growing prevalence of elderly people around the globe and the increasing number of blood collection facilities
  • Market Restraints
    • Presence of new pathogenic agents that resist the present viral inactivation treatments
  • Market Opportunities
    • Continuous advancements in process development technology for improved formulations
    • Exponential utilization in new clinical trials and growing R&D activities in plasma treatment
  • Market Challenges
    • Stringent government regulations on plasma fractionation and the presence of alternative recombinant therapies

Exploring Porter’s Five Forces for the Plasma Fractionation Market

Porter’s Five Forces framework further strengthens the insights of the Plasma Fractionation Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Plasma Fractionation Market

External macro-environmental factors deeply influence the performance of the Plasma Fractionation Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Plasma Fractionation Market

The Plasma Fractionation Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Plasma Fractionation Market

The Plasma Fractionation Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Plasma Fractionation Market

The Plasma Fractionation Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Plasma Fractionation Market, highlighting leading vendors and their innovative profiles. These include 3M Company, ADMA Biologics, Inc., Bharat Serums and Vaccines Limited, Bio Products Laboratory Ltd., Biotest AG by Grifols, S.A., China Biologic Products, Inc., CSL Limited, Emergent BioSolutions Inc., Fusion Health Care Pvt. Ltd., GC Biopharma corp., Grifols, S.A., HEINKEL Process Technology GmbH, Hemarus Therapeutics Ltd, Intas Pharmaceuticals Ltd., Kamada Ltd., Kedrion S.p.A., LFB SA, Merck KGaA, Octapharma AG, PlasmaGen BioSciences Pvt. Ltd., Prothya Biosolutions B.V., Sanquin, Shanghai Raas Blood Products Co. Ltd, SK Plasma Co.,Ltd., STERIS plc, and Takeda Pharmaceutical Company Ltd.

Market Segmentation & Coverage

This research report categorizes the Plasma Fractionation Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product
    • Albumin
    • Coagulation Factor Concentrates
      • Factor IX
      • Factor VIII
      • Factor XIII
      • Fibrinogen Concentrates
      • Prothrombin Complex Concentrate
      • Von Willebrand Factor
    • Immunoglobulin
      • Intravenous Immunoglobulin
      • Subcutaneous Immunoglobulin
    • Protease Inhibitors
  • Application
    • Critical Care
    • Hemato-Oncology
    • Hematology
    • Neurology
    • Pulmonology
    • Rheumatology
  • End-User
    • Academic & Research Institutes
    • Clinical Research Laboratories
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Improving access to plasma-based therapies and high use of immunoglobulins in various therapeutic areas
5.1.1.2. Government initiatives to increase plasma collection
5.1.1.3. Growing prevalence of elderly people around the globe and the increasing number of blood collection facilities
5.1.2. Restraints
5.1.2.1. Presence of new pathogenic agents that resist the present viral inactivation treatments
5.1.3. Opportunities
5.1.3.1. Continuous advancements in process development technology for improved formulations
5.1.3.2. Exponential utilization in new clinical trials and growing R&D activities in plasma treatment
5.1.4. Challenges
5.1.4.1. Stringent government regulations on plasma fractionation and the presence of alternative recombinant therapies
5.2. Market Segmentation Analysis
5.2.1. Product: Rising use of plasma fractionation for immunoglobulins purification
5.2.2. Application: Proliferating use to treat hematological disorders
5.2.3. End-User: Extensive use of plasma fractionation in clinical research laboratories to ensure the safety and efficacy of plasma-derived products
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Plasma Fractionation Market, by Product
6.1. Introduction
6.2. Albumin
6.3. Coagulation Factor Concentrates
6.4. Immunoglobulin
6.5. Protease Inhibitors
7. Plasma Fractionation Market, by Application
7.1. Introduction
7.2. Critical Care
7.3. Hemato-Oncology
7.4. Hematology
7.5. Neurology
7.6. Pulmonology
7.7. Rheumatology
8. Plasma Fractionation Market, by End-User
8.1. Introduction
8.2. Academic & Research Institutes
8.3. Clinical Research Laboratories
9. Americas Plasma Fractionation Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Plasma Fractionation Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Plasma Fractionation Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. Grifols Egypt delivers first plasma medicines made from Egyptian plasma donations
12.3.2. CSL's USD470 Million Plasma Fractionation Facility Opens in Marburg, Germany
12.3.3. Takeda to Invest 100 Billion JPY in a New Manufacturing Facility for Plasma-Derived Therapies in Japan
12.3.4. Kedrion presented at plasma fractionation workshop in Saudi Arabia
12.4. Strategy Analysis & Recommendation
13. Competitive Portfolio
13.1. Key Company Profiles
13.2. Key Product Portfolio
List of Figures
FIGURE 1. PLASMA FRACTIONATION MARKET RESEARCH PROCESS
FIGURE 2. PLASMA FRACTIONATION MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL PLASMA FRACTIONATION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. PLASMA FRACTIONATION MARKET DYNAMICS
FIGURE 7. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES PLASMA FRACTIONATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES PLASMA FRACTIONATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. PLASMA FRACTIONATION MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 22. PLASMA FRACTIONATION MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. PLASMA FRACTIONATION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL PLASMA FRACTIONATION MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL PLASMA FRACTIONATION MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY ALBUMIN, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY ALBUMIN, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY FACTOR IX, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY FACTOR IX, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY FACTOR VIII, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY FACTOR VIII, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY FACTOR XIII, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY FACTOR XIII, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY FIBRINOGEN CONCENTRATES, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY FIBRINOGEN CONCENTRATES, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY PROTHROMBIN COMPLEX CONCENTRATE, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY PROTHROMBIN COMPLEX CONCENTRATE, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY VON WILLEBRAND FACTOR, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY VON WILLEBRAND FACTOR, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY PROTEASE INHIBITORS, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY PROTEASE INHIBITORS, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY CRITICAL CARE, BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY CRITICAL CARE, BY REGION, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY HEMATO-ONCOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY HEMATO-ONCOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY HEMATOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY NEUROLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 47. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY PULMONOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 48. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY PULMONOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 49. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY RHEUMATOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 50. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY RHEUMATOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 51. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 52. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 53. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
TABLE 54. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
TABLE 55. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY CLINICAL RESEARCH LABORATORIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 56. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY CLINICAL RESEARCH LABORATORIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 57. AMERICAS PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 58. AMERICAS PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 59. AMERICAS PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2023 (USD MILLION)
TABLE 60. AMERICAS PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2024-2030 (USD MILLION)
TABLE 61. AMERICAS PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2023 (USD MILLION)
TABLE 62. AMERICAS PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2024-2030 (USD MILLION)
TABLE 63. AMERICAS PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 64. AMERICAS PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 65. AMERICAS PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 66. AMERICAS PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 67. AMERICAS PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 68. AMERICAS PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 69. ARGENTINA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 70. ARGENTINA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 71. ARGENTINA PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2023 (USD MILLION)
TABLE 72. ARGENTINA PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2024-2030 (USD MILLION)
TABLE 73. ARGENTINA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2023 (USD MILLION)
TABLE 74. ARGENTINA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2024-2030 (USD MILLION)
TABLE 75. ARGENTINA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 76. ARGENTINA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 77. ARGENTINA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 78. ARGENTINA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 79. BRAZIL PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 80. BRAZIL PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 81. BRAZIL PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2023 (USD MILLION)
TABLE 82. BRAZIL PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2024-2030 (USD MILLION)
TABLE 83. BRAZIL PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2023 (USD MILLION)
TABLE 84. BRAZIL PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2024-2030 (USD MILLION)
TABLE 85. BRAZIL PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 86. BRAZIL PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 87. BRAZIL PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 88. BRAZIL PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 89. CANADA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 90. CANADA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 91. CANADA PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2023 (USD MILLION)
TABLE 92. CANADA PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2024-2030 (USD MILLION)
TABLE 93. CANADA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2023 (USD MILLION)
TABLE 94. CANADA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2024-2030 (USD MILLION)
TABLE 95. CANADA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 96. CANADA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 97. CANADA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 98. CANADA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 99. MEXICO PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 100. MEXICO PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 101. MEXICO PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2023 (USD MILLION)
TABLE 102. MEXICO PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2024-2030 (USD MILLION)
TABLE 103. MEXICO PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2023 (USD MILLION)
TABLE 104. MEXICO PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2024-2030 (USD MILLION)
TABLE 105. MEXICO PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 106. MEXICO PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 107. MEXICO PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 108. MEXICO PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 109. UNITED STATES PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 110. UNITED STATES PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 111. UNITED STATES PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2023 (USD MILLION)
TABLE 112. UNITED STATES PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2024-2030 (USD MILLION)
TABLE 113. UNITED STATES PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2023 (USD MILLION)
TABLE 114. UNITED STATES PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2024-2030 (USD MILLION)
TABLE 115. UNITED STATES PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 116. UNITED STATES PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 117. UNITED STATES PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 118. UNITED STATES PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 119. UNITED STATES PLASMA FRACTIONATION MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 120. UNITED STATES PLASMA FRACTIONATION MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 121. ASIA-PACIFIC PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 122. ASIA-PACIFIC PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 123. ASIA-PACIFIC PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2023 (USD MILLION)
TABLE 124. ASIA-PACIFIC PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2024-2030 (USD MILLION)
TABLE 125. ASIA-PACIFIC PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2023 (USD MILLION)
TABLE 126. ASIA-PACIFIC PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2024-2030 (USD MILLION)
TABLE 127. ASIA-PACIFIC PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 128. ASIA-PACIFIC PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 129. ASIA-PACIFIC PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 130. ASIA-PACIFIC PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 131. ASIA-PACIFIC PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 132. ASIA-PACIFIC PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 133. AUSTRALIA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 134. AUSTRALIA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 135. AUSTRALIA PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2023 (USD MILLION)
TABLE 136. AUSTRALIA PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2024-2030 (USD MILLION)
TABLE 137. AUSTRALIA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2023 (USD MILLION)
TABLE 138. AUSTRALIA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2024-2030 (USD MILLION)
TABLE 139. AUSTRALIA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 140. AUSTRALIA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 141. AUSTRALIA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 142. AUSTRALIA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 143. CHINA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 144. CHINA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 145. CHINA PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2023 (USD MILLION)
TABLE 146. CHINA PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2024-2030 (USD MILLION)
TABLE 147. CHINA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2023 (USD MILLION)
TABLE 148. CHINA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2024-2030 (USD MILLION)
TABLE 149. CHINA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 150. CHINA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 151. CHINA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 152. CHINA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 153. INDIA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 154. INDIA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 155. INDIA PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2023 (USD MILLION)
TABLE 156. INDIA PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2024-2030 (USD MILLION)
TABLE 157. INDIA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2023 (USD MILLION)
TABLE 158. INDIA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2024-2030 (USD MILLION)
TABLE 159. INDIA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 160. INDIA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 161. INDIA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 162. INDIA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 163. INDONESIA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 164. INDONESIA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 165. INDONESIA PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2023 (USD MILLION)
TABLE 166. INDONESIA PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2024-2030 (USD MILLION)
TABLE 167. INDONESIA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2023 (USD MILLION)
TABLE 168. INDONESIA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2024-2030 (USD MILLION)
TABLE 169. INDONESIA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 170. INDONESIA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 171. INDONESIA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 172. INDONESIA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 173. JAPAN PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 174. JAPAN PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 175. JAPAN PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2023 (USD MILLION)
TABLE 176. JAPAN PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2024-2030 (USD MILLION)
TABLE 177. JAPAN PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2023 (USD MILLION)
TABLE 178. JAPAN PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2024-2030 (USD MILLION)
TABLE 179. JAPAN PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 180. JAPAN PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 181. JAPAN PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 182. JAPAN PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 183. MALAYSIA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 184. MALAYSIA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 185. MALAYSIA PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2023 (USD MILLION)
TABLE 186. MALAYSIA PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2024-2030 (USD MILLION)
TABLE 187. MALAYSIA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2023 (USD MILLION)
TABLE 188. MALAYSIA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2024-2030 (USD MILLION)
TABLE 189. MALAYSIA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 190. MALAYSIA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 191. MALAYSIA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 192. MALAYSIA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 193. PHILIPPINES PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 194. PHILIPPINES PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 195. PHILIPPINES PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2023 (USD MILLION)
TABLE 196. PHILIPPINES PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2024-2030 (USD MILLION)
TABLE 197. PHILIPPINES PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2023 (USD MILLION)
TABLE 198. PHILIPPINES PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2024-2030 (USD MILLION)
TABLE 199. PHILIPPINES PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 200. PHILIPPINES PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 201. PHILIPPINES PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 202. PHILIPPINES PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 203. SINGAPORE PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 204. SINGAPORE PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 205. SINGAPORE PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2023 (USD MILLION)
TABLE 206. SINGAPORE PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2024-2030 (USD MILLION)
TABLE 207. SINGAPORE PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2023 (USD MILLION)
TABLE 208. SINGAPORE PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2024-2030 (USD MILLION)
TABLE 209. SINGAPORE PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 210. SINGAPORE PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 211. SINGAPORE PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 212. SINGAPORE PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 213. SOUTH KOREA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 214. SOUTH KOREA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 215. SOUTH KOREA PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2023 (USD MILLION)
TABLE 216. SOUTH KOREA PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2024-2030 (USD MILLION)
TABLE 217. SOUTH KOREA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2023 (USD MILLION)
TABLE 218. SOUTH KOREA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2024-2030 (USD MILLION)
TABLE 219. SOUTH KOREA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 220. SOUTH KOREA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 221. SOUTH KOREA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 222. SOUTH KOREA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 223. TAIWAN PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 224. TAIWAN PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 225. TAIWAN PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2023 (USD MILLION)
TABLE 226. TAIWAN PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2024-2030 (USD MILLION)
TABLE 227. TAIWAN PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2023 (USD MILLION)
TABLE 228. TAIWAN PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2024-2030 (USD MILLION)
TABLE 229. TAIWAN PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 230. TAIWAN PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 231. TAIWAN PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 232. TAIWAN PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 233. THAILAND PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 234. THAILAND PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 235. THAILAND PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2023 (USD MILLION)
TABLE 236. THAILAND PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2024-2030 (USD MILLION)
TABLE 237. THAILAND PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2023 (USD MILLION)
TABLE 238. THAILAND PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2024-2030 (USD MILLION)
TABLE 239. THAILAND PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 240. THAILAND PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 241. THAILAND PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 242. THAILAND PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 243. VIETNAM PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 244. VIETNAM PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 245. VIETNAM PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2023 (USD MILLION)
TABLE 246. VIETNAM PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2024-2030 (USD MILLION)
TABLE 247. VIETNAM PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2023 (USD MILLION)
TABLE 248. VIETNAM PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2024-2030 (USD MILLION)
TABLE 249. VIETNAM PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 250. VIETNAM PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 251. VIETNAM PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 252. VIETNAM PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2023 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2024-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2023 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2024-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 265. DENMARK PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 266. DENMARK PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 267. DENMARK PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2023 (USD MILLION)
TABLE 268. DENMARK PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2024-2030 (USD MILLION)
TABLE 269. DENMARK PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2023 (USD MILLION)
TABLE 270. DENMARK PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2024-2030 (USD MILLION)
TABLE 271. DENMARK PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 272. DENMARK PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 273. DENMARK PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 274. DENMARK PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 275. EGYPT PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 276. EGYPT PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 277. EGYPT PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2023 (USD MILLION)
TABLE 278. EGYPT PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2024-2030 (USD MILLION)
TABLE 279. EGYPT PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2023 (USD MILLION)
TABLE 280. EGYPT PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2024-2030 (USD MILLION)
TABLE 281. EGYPT PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 282. EGYPT PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 283. EGYPT PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 284. EGYPT PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 285. FINLAND PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 286. FINLAND PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 287. FINLAND PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2023 (USD MILLION)
TABLE 288. FINLAND PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2024-2030 (USD MILLION)
TABLE 289. FINLAND PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2023 (USD MILLION)
TABLE 290. FINLAND PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2024-2030 (USD MILLION)
TABLE 291. FINLAND PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 292. FINLAND PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 293. FINLAND PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 294. FINLAND PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 295. FRANCE PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 296. FRANCE PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 297. FRANCE PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2023 (USD MILLION)
TABLE 298. FRANCE PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2024-2030 (USD MILLION)
TABLE 299. FRANCE PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2023 (USD MILLION)
TABLE 300. FRANCE PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2024-2030 (USD MILLION)
TABLE 301. FRANCE PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 302. FRANCE PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 303. FRANCE PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 304. FRANCE PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 305. GERMANY PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 306. GERMANY PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 307. GERMANY PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2023 (USD MILLION)
TABLE 308. GERMANY PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2024-2030 (USD MILLION)
TABLE 309. GERMANY PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2023 (USD MILLION)
TABLE 310. GERMANY PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2024-2030 (USD MILLION)
TABLE 311. GERMANY PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 312. GERMANY PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 313. GERMANY PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 314. GERMANY PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 315. ISRAEL PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 316. ISRAEL PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 317. ISRAEL PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2023 (USD MILLION)
TABLE 318. ISRAEL PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2024-2030 (USD MILLION)
TABLE 319. ISRAEL PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2023 (USD MILLION)
TABLE 320. ISRAEL PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2024-2030 (USD MILLION)
TABLE 321. ISRAEL PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 322. ISRAEL PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 323. ISRAEL PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 324. ISRAEL PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 325. ITALY PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 326. ITALY PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 327. ITALY PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2023 (USD MILLION)
TABLE 328. ITALY PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2024-2030 (USD MILLION)
TABLE 329. ITALY PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2023 (USD MILLION)
TABLE 330. ITALY PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2024-2030 (USD MILLION)
TABLE 331. ITALY PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 332. ITALY PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 333. ITALY PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 334. ITALY PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2

Companies Mentioned

The leading players in the Plasma Fractionation market, which are profiled in this report, include:
  • 3M Company
  • ADMA Biologics, Inc.
  • Bharat Serums and Vaccines Limited
  • Bio Products Laboratory Ltd.
  • Biotest AG by Grifols, S.A.
  • China Biologic Products, Inc.
  • CSL Limited
  • Emergent BioSolutions Inc.
  • Fusion Health Care Pvt. Ltd.
  • GC Biopharma corp.
  • Grifols, S.A.
  • HEINKEL Process Technology GmbH
  • Hemarus Therapeutics Ltd
  • Intas Pharmaceuticals Ltd.
  • Kamada Ltd.
  • Kedrion S.p.A.
  • LFB SA
  • Merck KGaA
  • Octapharma AG
  • PlasmaGen BioSciences Pvt. Ltd.
  • Prothya Biosolutions B.V.
  • Sanquin
  • Shanghai Raas Blood Products Co. Ltd
  • SK Plasma Co.,Ltd.
  • STERIS plc
  • Takeda Pharmaceutical Company Ltd

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages188
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 38.95 Billion
Forecasted Market Value ( USD ) by 2030 $ 71.27 Billion
Compound Annual Growth Rate10.4%
Regions CoveredGlobal
No. of Companies Mentioned27

Related Topics

Related Reports

Plasma Fractionation Market Report by Product, Sector, Application, End User, and Region 2024-2032 - Product Image

Plasma Fractionation Market Report by Product, Sector, Application, End User, and Region 2024-2032

  • Report
  • 137 Pages
  • Global
From
Plasma Fractionation Global Market Report 2024 - Product Image

Plasma Fractionation Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Plasma Fractionation - Global Strategic Business Report - Product Image

Plasma Fractionation - Global Strategic Business Report

  • Report
  • 245 Pages
  • Global
From
Plasma Fractionation Market 2024-2028 - Product Image

Plasma Fractionation Market 2024-2028

  • Report
  • 163 Pages
  • Global
From
Plasma Fractionation Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Plasma Fractionation Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 95 Pages
  • Global
From

About the Market

The Plasma Fractionation market is a subset of the Blood Banking industry, which involves the collection, processing, and distribution of human blood and its components. Plasma fractionation is the process of separating plasma from whole blood, which is then used to produce a variety of therapeutic proteins and other products. These products are used to treat a variety of conditions, including hemophilia, immune deficiencies, and other rare diseases. Plasma fractionation also plays an important role in the production of vaccines and other biopharmaceuticals. The Plasma Fractionation market is highly competitive, with a number of companies offering a range of products and services. Some of the major players in the market include CSL Behring, Grifols, Octapharma, Kedrion, and Biotest. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.